Agent Capital is a healthcare venture capital firm dedicated to investing in novel, differentiated therapeutics and treatments that address unmet patient needs. They focus on making direct equity investments across all stages of development, from preclinical to commercial. Their team partners with scientists, entrepreneurs, and other investors to develop the next generation of healthcare innovations, with a particular emphasis on rare diseases, oncology, neurology, and immunology.
| Fund Size | N/A USD |
| Stages Focus | Preclinical, Clinical, Commercial, Pre-Seed, Seed, Series A |
| Sectors Focus | Healthcare, Biotech |
| Portfolio Size | 20 companies |
Agent Capital's investment thesis is centered on addressing unmet patient needs through novel, differentiated therapeutics and treatments. They invest across all stages of development, from preclinical to commercial, with a particular focus on sectors such as rare diseases, oncology, neurology, and immunology. Their approach is characterized by a balanced investment strategy and a deep understanding of the pressures within the biopharma pipeline.
Active team contains 4 members (0 partners, 2 founders).
Agent Capital is a healthcare venture capital firm dedicated to investing in novel, differentiated therapeutics and treatments that address unmet patient needs. They focus on sectors such as rare diseases, oncology, neurology, and immunology, investing across all stages of development from preclinical to commercial.
Investor Profile: Agent Capital on EzFunding
Agent Capital's investment strategy is centered on addressing unmet patient needs through novel, differentiated therapeutics and treatments. They invest across all stages of development, from preclinical to commercial, with a particular focus on sectors such as rare diseases, oncology, neurology, and immunology.
Investor Profile: Agent Capital on EzFunding
Agent Capital is located in Waltham, USA.
Investor Profile: Agent Capital on EzFunding
The typical check sizes for Agent Capital range from $250,000 to $15,000,000 USD.
Investor Profile: Agent Capital on EzFunding
No, Agent Capital does not accept cold outreach.
Investor Profile: Agent Capital on EzFunding
The key team members at Agent Capital are Geeta Vemuri, Preston Noon, Anthony DiNatale, and Kirti Nimmala.
Investor Profile: Agent Capital on EzFunding
The founding date of Agent Capital is not publicly available.
Investor Profile: Agent Capital on EzFunding
Agent Capital invests in the healthcare and biotech sectors, focusing on novel, differentiated therapeutics and treatments that address unmet patient needs.
Investor Profile: Agent Capital on EzFunding
Agent Capital focuses on all stages of investment, including preclinical, clinical, commercial, pre-seed, seed, and series A.
Investor Profile: Agent Capital on EzFunding
Agent Capital invests in North America and Europe.
Investor Profile: Agent Capital on EzFunding